(+/-)-SLV 319
CAS: 362519-49-1
Ref. 3D-MPA51949
| 5mg | Ausgelaufen | ||
| 10mg | Ausgelaufen | ||
| 25mg | Ausgelaufen | ||
| 50mg | Ausgelaufen | ||
| 100mg | Ausgelaufen |
Produktinformation
Name:
(+/-)-SLV 319
Beschreibung:
(+/-)-SLV 319 is a cannabinoid receptor agonist. It binds to the CB2 receptor, which is expressed in the bowel and on immune cells. This drug has been shown to have anti-inflammatory effects in animal studies for inflammatory bowel disease and colitis, as well as anti-diarrheal activity. SLV 319 has also been shown to be an effective treatment for metabolic disorders such as diabetes and obesity in vivo models. (+/-)-SLV 319 inhibits fatty acid synthase, which is an enzyme that synthesizes fatty acids from acetyl-CoA, resulting in decreased levels of these molecules. The drug also has the ability to increase glucose uptake by both sodium-dependent glucose transporters (SGLT) and GLUT4 transporters.
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
487.41 g/mol
Formel:
C23H20Cl2N4O2S
Reinheit:
Min. 95%
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:
